提交活动资讯

2021年第14届国际系统性红斑狼疮大会(LUPUS 2021) /2021年第6届国际风湿病和自身免疫争议大会(CORA)

生物博览会|检验会议|病理大会|感染会议|免疫研讨会|公共卫生博览会|


会议地点: 在线会议-Online
会议时间: 2021年10月6-9日
行业: 生物|检验|病理|感染|免疫|公共卫生会议

会议简介:


2021第14届国际系统性红斑狼疮大会(LUPUS 2021)/第6届国际风湿病和自身免疫争议大会(CORA)将于2021年10月6-9日以线上会议形式举行。LUPUS2021将重点介绍近期SLE和自身免疫领域在临床、生物学和转化方面的最新进展;大会将包括一个针对实验室科学与临床转化之间联系的特殊计划,包括从B细胞到肾炎的主题的多学科会议,并为展示原始数据提供独特的机会。CORA2021将涵盖与风湿性关节炎、银屑病性关节炎、脊柱关节病、系统性硬化症、纤维肌痛等风湿性和自身免疫性疾病的临床诊断、治疗和发病机制有关的争议性话题,以及生物制剂和生物仿制药等治疗问题;科学家们将对具争议性和紧迫性的问题进行辩论。

LUPUS & CORA 2021 Congress | 6-9 October | online

摘要:

9 February 2021 : Abstract Submission Open
2 June 2021 : Abstract Submission Deadline (midnight CET)
July 2021 : Abstract Notifications

点此提交摘要>>>Submit Abstract>>>

Topics for LUPUS

  • Antimalarials
  • Antiphospholipid syndrome
  • Biomarkers in SLE
  • Diagnosis, classification and SLE mimickers
  • Disease activity and disease flares
  • COVID and lupus
  • Environmental, epigenetics and genomics
  • Epidemiology
  • Family planning, fertility, pregnancy and neonatal care
  • Innate and adaptive immunity
  • Management and recommendations
  • Microbiome, infections, probiotics and nutritional factors in SLE
  • New therapies and therapeutic targets in SLE
  • Pathogenetic and protective autoantibodies
  • Patient reported outcomes
  • Patient-submitted abstracts
  • Paediatric SLE
  • Personalised medicine in SLE
  • Quality of Life in SLE
  • Late onset SLE
  • Registries and cohorts
  • SLE Complications and comorbidities
  • SLE Organ manifestations: clinical and pathogenesis
  • SLE Prognosis
  • Treat to Target, remission and low-disease activity
  • Update in clinical trials

Topics for CORA

  • Advances in Autoantibody Testing
  • Ankylosing Spondylitis
  • Antiphospholipid Syndrome
  • Autoinflammatory Diseases
  • Biological Drugs
  • Biomarkers in Autoimmune Rheumatic Conditions
  • Biosimilars
  • Checkpoint Inhibitors Induced Autoimmunity
  • Comorbidity in Rheumatic and Autoimmune Diseases
  • COVID-19 and Autoimmunity
  • Environment, Vaccination, Adjuvants (Asia Syndrome)
  • Etiology, Genetics and Mechanisms in Rheumatic and Autoimmune Diseases
  • Fibromyalgia, Chronic Pain and Pain Relief
  • Gout
  • Il17, Th17 And Cytokines in Autoimmunity
  • Immunometabolism And Autoimmunity
  • Infection and Autoimmunity: Microbiome, Infectome And Interactome
  • Ivig And Natural Autoantibodies
  • Miscellaneous
  • Novel Aspects of Therapies – Biosimilars
  • Novel Therapeutic Targets in Rheumatic and Autoimmune Diseases
  • Organ Involvement in Autoimmune Rheumatic Diseases
  • Polymyositis and Dermatomyositis
  • Pregnancy and Autoimmunity
  • Psoriatic Arthritis
  • Pulmonary Arterial Hypertension and Systemic Sclerosis
  • Refractory Autoimmune Diseases
  • Rheumatoid Arthritis
  • Small Molecules and Inhibitors
  • Spondyloarthritis
  • Spondyloarthropathies
  • Sjögren’s Disease
  • Systemic Lupus Erythematosus
  • Thyroid Autoimmunity
  • Vasculitides

 


 

Welcome Letter

It is a great pleasure to invite you to be part of the  14th International Congress on SLE, in Venice, Italy which will be held on October 6-9, 2021  together with the 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA). 

In 2021, the world of SLE will be at a crossroads. Advances in technology mean that it is now possible to address virtually any biological target with a specific therapy. Across diseases like rheumatoid arthritis and many types of cancer, this has meant life-changing and life-saving new therapies, while a similar progress has been frustratingly slower in SLE. However, laboratory research, bench-to-bedside approach with translation of novel discoveries into therapeutic agents, and the ability to successfully evaluate new molecules in clinical trials, have accelerated dramatically in recent years, rejuvenating a solid hope among researchers and physicians  who care about SLE patients. Application of the treat-to-target strategy to SLE was made possible by the joint effort of experts to pinpoint the most promising targets to treat patients to, leading to optimization of available treatments. Additionally, precision medicine is emerging nowadays in SLE, highlighting the need of committing basic research to a clinical applicability, thereby creating an inseparable duo between scientific progress and improvement of patients prognosis, gathering together different expertise and altogether offering to the scientific SLE community, as well as to drug developers and patients, a good reason to believe in a ‘new dawn’ of SLE management.

The LUPUS 2021 Congress will showcase the very best clinical, biological, and translational advances in the field of SLE and autoimmunity. The Congress will include an exceptional program focusing on the nexus between laboratory science and clinical translation, include multidisciplinary sessions on topics from B cells to nephritis, and offer a unique opportunity for the presentation of original data.

The CORA 2021 will cover controversial topics relating to clinical diagnosis, management, and pathogenesis of rheumatic and autoimmune disorders including rheumatoid arthritis, psoriatic arthritis, spondyloarthropathies, systemic sclerosis, fibromyalgia as well as therapeutic issues such as biologics and biosimilars. All the highly controversial and burning issues will be discussed in the intuitive and theatrical debate sessions where scientists fight each other in order to actively defend their own convictions

The chance of holding a meeting with a twin soul by joining the Lupus with the CORA meeting will not only widen the topics panorama, but will provide the chance of dissecting critical issues in detail, accommodating debates and different points of view explained by selected experts, thereby summarizing current data and exploring different faces of complex autoimmune systemic diseases.

We are delighted to have this conference taking place in Venice – a symbol for the whole country and the capital of northern Italy’s Veneto region, which is built on more than 100 small islands in a lagoon in the Adriatic Sea.

Few cities can claim such a priceless art and history heritage as Venice. This unique city with its magical, spectacular scenery is not just beautiful; it is a real miracle of creative genius where culture, architecture, art and commerce could could flourish on  the slime of an inhospitable landscape, thereby successfully overcoming the surrounding hurdles and establishing a prosperous balance lasting until today.

Therefore, I most cordially invite you to join us in Venice, at the 14th International Congress on SLE in 2021, in collaboration with the 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA), and make an incomparable difference.

 

Prof. Andrea Doria
LUPUS & CORA 2021 Congress Chair

 


 

注册费:

REGISTRATION
CATEGORIES
EARLY RATE
UNTIL SEPTEMBER 1, 2021
REGULAR  RATE
FROM SEPTEMBER 2, 2021
Delegate €290 €340
Delegates from Low & Lower-middle Income Countries* €200 €250
Trainee ** €170 €200
Allied Health Care Professional *** €180 €230
​Patient **** €60 €60

*Low&Lower-middle income countries: Countries classification is defined according to the World Bank Country Classification. . Click here for more information on the Country Classification data according to the World Bank website.

**The Trainee registration is available for “Clinicians in Training” and “non-Tenured Scientists” (scientist not being professor or associate professor) under 35 years of age. A letter of confirmation of your status from the Head of Unit or Institute must accompany the formal registration form.

*** Refers to: Nurse/Physiotherapist/Psychologist/Dietician/Social Worker/ Occupational Therapist/Audiologist – in order to benefit from the special fee, a submission of your status confirmation (approval letter signed by the Head of Department or copy of your status ID) must be uploaded during the online registration.

**** Patients can attend the congress scientific sessions but not the sponsored (promotional) sessions or the exhibition.

 

The Virtual Conference will offer you a full virtual experience and the opportunity to take part in every aspect of the program, including
  • Access all presentations and session recordings.
  • Create your own schedule to attend any and all of the sessions whenever and wherever you choose.
  • Network with colleagues. Browse the list of participants and click on their name to contact them.
  • Earn CME credits. Participate in the scientific program and be eligible to receive the number of CME credits attributed to the online meeting.
  • Access all the e-posters. Browse research on the hottest topics published in the meeting digital abstract book and connect with the abstract authors and other colleagues from around the world through the e-poster online consultations.
  • Join the Live QA sessions.
  • Visit the online exhibition hall. Journey through the exhibition booths, explore the displayed materials, contact exhibitors directly, and chat with other visitors.

 




会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。


免责条款:本站信息均收集整理自互联网,访问者如需了解更多详情,请进入相关活动官网,本站不对相关信息的准确性承担任何责任; 若本站的资讯侵害您的权益,请发送邮件到[email protected],本站将在核实相关情况后第一时间删除。继续访问本站视为认同以上条款。


更多会议活动:
2022年第111届日本病理学会(JSP)春季年会
2022年第24届国际临床化学与检验医学大会
2021年第28届国际生物力学学会大会
2022年第8届欧洲病毒学大会
2022年第75届普通生理学家学会年度研讨会
2022年第59届澳大利亚临床生物化学与检验医学协会年会
2021中国生命科学大会暨中国生命科学博览会(CLSE)
2022年美国生物材料学会-日本生物材料学会联合研讨会
2022年英国微生物学会年会
2023年第2届世界病毒学会大会(WSV2023)


© www.canhui.org | 免责条款 | 提交活动信息 More information contact [email protected]